Introduction
The bcl-2 family of proteins can either promote or inhibit cell death. It was proposed that the ratio of pro-survival to pro-death members of this family determines the propensity of a cell to live or die. 1, 2 Because anti-apoptotic proteins, bcl-2 and bcl-xL, are often enhanced in various cancers, where they may play a pivotal role in tumor initiation and progression, 3, 4 bcl-2 and bcl-xL genes were suggested to be targets for cancer gene therapy. Administrations of bcl-2 and bcl-xL antisense oligonucleotides promoted apoptosis and inhibited cell growth in brest carcinoma cells 5 and small-cell lung cancer cells, 6 in which bcl-2 or bcl-xL was detectable. In our previous report, 7 we examined the effects of in vivo electroporetic transfer of a bcl-2 antisense oluigonucleotide phosphorothioate on rat hepatocarcinogenesis, and showed that bcl-2 antisense oligonucleotide inhibited expression of bcl-2 mRNA and the occurrence and growth of rat hepatocellular carcinoma induced by NNM. The selective administration of a bcl-2 antisense oligonucleotide may thus provide an also increased with increasing doses of plasmid, meaning that in vivo electroporation enabled the expression of plasmid DNA throughout an extensive area of the rat liver. By week 11, the neoplastic nodules were significantly fewer and smaller in the bcl-xs group than in the pCR3.1 group at the two sites, one with and the other without electrode contact. No hepatocellular carcinomas were found in the rats that had received the bcl-xs plasmid, whereas these tumors were observed in 30% of the rats given pCR3. 1 effective therapy for liver tumors. However, since not all human liver tumors overexpress bcl-2 protein, 8 bcl-2 antisense would probably be effective for all types of liver tumors.
. Moreover, overexpression of the bcl-xs protein was detected, and apoptotic activity was significantly increased in the neoplastic nodules, foci and hepatocytes adjacent to the hepatic lesions. These results indicate that the bcl-xs plasmid inhibits the occurrence and growth of rat hepatocellular carcinoma and may
Among the pro-apoptotic bcl-2 family members, bcl-xs is unique in that it lacks BH-1 and BH-2 domains, which constitute part of the membrane spanning-domains of bcl-2, bcl-xL and bax. Bcl-xs, however, has BH-3 as well as BH-4 domains, whch enable it to interact outside the bcl-2 family. 9 Bcl-xs is thus thought to act either by binding to and inactivating the pro-survival functions of bcl-2 and bcl-xL, or by displacing pro-death bcl-2 family member such as bax, from bcl-2 or bcl-xL, thereby allowing it to kill cells. 10 However, it was recently reported that bcl-xs induces acute cell death in 3T3 cells by a novel cell death pathway that does not utilize caspases. 11, 12 Infection with a bcl-xs adenovirus vector effectively killed human mammary tumor cells and decreased their growth in transplanted murine tumors. 13 In addition, it has been shown that c-myc-or c-erb-2-transformed murine mammary cells are extremely sensitive to apoptosis induced by bcl-xs adenovirus vector as compared with non-transformed cells.
14 Most liver tumors overexpress c-myc, 15, 16 and may be sensitive to apoptosis induced by exogenous bcl-xs. These findings indicate that bcl-xs gene is more effective for various types of liver tumors than antisense oligonucleotides of the anti-apoptotic bcl-2 family.
In humans, liver cirrhosis is known to predispose to liver tumors and also to frequently be associated with recurrence of liver tumors. 17, 18 Therefore, in this experiment, we observed the effect of bcl-xs gene on the sequence from hepatic precancerous lesions, foci and neoplastic nodules, to hepatocellular carcinomas, which was obtained by giving rats NNM in drinking for 8 weeks. 19 Since antisense oligonucleotides are cleaved in vivo within a short time, despite chemical modification of phosphodiester linkages, 20 a higher dose than that of the plasmid or viral vectors is necessary for treatment, resulting in toxicity. However, viral vectors have the limitations such as the possibility of insertional mutagenesis or induction of a host immune response, despite inducing high long-term gene expression. 21 On the other hand, plasmid DNA is neither replicated nor integrated into the host cell genome, but remains in its episomal form, 22 and gene therapy with plasmid DNA is a rapidly expanding field. [23] [24] [25] Moreover, in vivo electroporation can transfer DNA into most cells including skin, liver and tumor cells, as well as to both proliferating and nonproliferating cells. [26] [27] [28] Therefore, to examine the effectiveness of the bcl-xs gene in preventing the occurrence and inhibiting the growth of liver tumors, we encapsulated bcl-xs plasmids in cationic empty liposomes, which assured particles with a constant diameter, and injected them directly into the NNM-treated rat liver, and then performed in vivo electroporation.
Results

CAT expression in rat liver
The pCR3.1-CAT plasmid (Invitrogen), containing the chloramphenicol acetyl transferase gene (CAT cDNA fragment, 659 bp) downstream from the CMV promoter in pCR3.1 as a reporter gene, was used to examine the extent of the area into which the plasmid had been transferred, in the left hepatic lobe and in which bcl-xs mRNA was expressed. Sprague-Dawley rats were randomly divided into two groups of six rats each and each group was then subdivided into three subgroups of two rats. All rats were injected with 15 mg/kg sodium pentobarbital intraperitoneally. After complete anesthesia, the left lobe of the liver was exposed and then injected with pCR3.1-CAT at doses of 40, 80 or 120 g/kg body weight, as plasmids encapsulated in empty liposomes which assured particles with a constant diameter. One minute later, in three of the subgroups, the site where the plasmid had been injected was sandwiched in a pincette electrode with circle poles 1 cm in diameter (positive and negative) ( Figure  1a) . Eight electrical pulses, with a current of 0.5 A, electric-field strength of 70-100 V/cm and a pulse duration of 50 ms, were delivered to the left lobe. However, in the other three subgroups injected with plasmids, in vivo electroporation was not performed. Three days later, three segments (20-30 mg) (a, b, c) were taken from each section of the left lobe of the liver, ie a sandwiched section and a non-sandwiched section (Figure 1b) . The segments were examined by RT-PCR for CAT mRNA. CAT mRNA was found to be expressed in all three segments (a, b, c) at the sites of electrode contact in rat livers that had been injected with 40, 80 or 120 g CAT plasmid/kg ( Figure 2a) . CAT mRNA was also expressed at sites 0.5-1.0 cm from the point of electrode contact in rat liver tissue that had received 80 or 120 g plasmid/kg ( Figure  2b ). The expression of CAT mRNA at sites some distance from the electrode was weaker than at sites of electrode contact. However, both at sites of electrode contact and at those some distance from the electrode, expression By contrast, in rat livers injected with CAT plasmid encapsulated in liposomes, but not exposed to in vivo electroporation, CAT mRNA was expressed only in liver tissues injected with 80 or 120 g plasmid/kg, but not in liver tissues injected with 40 g plasmid/kg. Moreover, expressions in the three segments were not at the same levels (Figures 2a and 3a) . No CAT mRNA was expressed in any segments corresponding to sites 0.5-1.0 cm from the point of electrode contact (Figure 2b ). There was no CAT expression in rat livers injected with pCR3.1 regardless of whether or not in vivo electroporation was performed ( Figure 2a ).
In addition, to examine the effect of empty liposomes on in vivo electroporation, four Sprague-Dawley rats were divided into two groups and then injected with 80 g/kg of pCR3.1-CAT (encapsulated in empty liposomes) and naked pCR3.1-CAT, respectively. Next, in vivo electroporation was perfomed in the two groups. In the two groups, CAT mRNA was expressed not only at sites of electrode contact but also at sites away from electrode. However, the expression of CAT mRNA was approximately two times higher in the liver tissues given These results show that the reporter gene was expressed not only in tissues exposed to electric pulses, but also in tissues some distance from the point of electrode contact, and that empty liposomes increased electroporetic transfer of CAT plasmid. Plasmids encapsulated in empty liposomes have been transferred into a significant wide area of rat liver by in vivo electroporation with the pincette electrode.
Effect of bcl-xs gene transfer on liver tumor growth
To assess the therapeutic effect of the bcl-xs gene on liver tumors, plasmid pCR3.1-bcl-xs was electroporetically transferred into the livers of rats treated with NNM. Rat bcl-xs cDNA (576 bp) was produced by RT-PCR using total RNA extracted from Sprague-Dawley rat spleens and was subcloned by insertion into the downstream CMV promoter of pCR3.1. Rats were divided randomly into three groups of 20 rats each and given drinking water containing 175 mg/l NNM for 8 weeks. In this experimental model, the progression of hepatocellular carcinoma can be observed as a sequence from precancerous lesions to hepatocellular carcinoma. Histological Figure 5 ). There were no precancerous lesions, foci or neoplastic nodules, for the 2 weeks starting at the beginning of the experiment. At week 3, foci, areas of cellular alterations, appeared and began to grow, and at week 7 neoplastic nodules, which were composed of more alternative cells than foci, manifested from foci and began to grow. When administration of NNM was stopped at week 8, more than 95% of precancerous lesions had undergone remodeling and only less than 1% of residual irreversible lesions had progressed to hepatocellular carcinoma. Tumor-bearing rats survived until more than 20 weeks.
At weeks 1, 4 and 7, pCR3.1-bcl-xs encapsulated in empty liposomes (group 1), pCR3.1 encapsulated in liposomes (group 2), or liposomes only (group 3) were injected into the left hepatic lobes of rats, at a dose of 80 g/kg body weight, and these injections were followed by in vivo electroporation. At week 11, there were no differences in the numbers and size of the foci at the sites that received the electric pulses in groups 1 (pCR3.1-bclxs), 2 (pCR3.1) and 3 (liposomes), and also there was no difference in the size of the foci at sites away from electrode in groups 1, 2 and 3. However, neoplastic nodules, were significantly fewer and smaller in group 1 than in groups 2 and 3 (Figure 6a and b) . Moreover, the incidences of hepatocellular carcinoma revealed bcl-xs to have completely inhibited the development of hepatocellular carcinoma both at sites of electrode contact and at sites away from the electrode though hepatocellular carcinomas were present in groups 2 and 3 to the same extent (Table 1) .
These results show that three electroporetic transfers of bcl-xs plasmids encapsulated in liposomes inhibited the conversion of foci into neoplastic nodules and the development of hepatocellular carcinoma, and that the effect of bcl-xs extended even to sites 0.5-1.0 cm away from the point of electrode contact.
Western blotting for bcl-xs protein
At week 11, bcl-xs protein was expressed at sites of electrode contact in group 1 (pCR3.1-bcl-xs), and also expressed at sites away from electrode in the liver although less than at sites of electrode contact. However, there was no expression of bcl-xs protein in group 2 (pCR3.1) at both sites of electrode contact and sites away from electrode. On the other hand, at both sites of electrode contact and sites away from electrode, bcl-xL protein was expressed in groups 1 and 2 to the same degree ( Figure 7 ). These results show that bcl-xs has overexpressed by transfer of the bcl-xs plasmid and that exogenous bcl-xs plasmid did not affect the transcription of bcl-xL, an alternative splicing product of bcl-xs.
Apoptotic index
In situ labeling of new 3Ј-OH of the DNA fragments generated by apoptosis-associated endonuclease was used to identify apoptotic cells at sites of electrode contact and at sites away from electrode. In group 1 (pCR3.1-bcl-xs), the apoptotic index in the preneoplastic nodules, foci and hepatocytes adjacent to the hepatic lesions was significantly higher than in groups 2 (pCR3.1) and 3 (liposomes), but there was no difference in the apoptotic index in the neoplastic nodules, foci and hepatocytes adjacent to the hepatic lesions in groups 2 and 3 at both the sites of electrode contact and away from electrode (Figure 8a and b) .
These results show that inhibition of the development of hepatocellular carcinomas by bcl-xs plasmid caused the pro-apoptotic activity of bcl-xs protein.
Discussion
Transfer of the bcl-xs plasmids by in vivo electroporation into the livers of rats that had consumed NNM induced overexpression of the bcl-xs protein in liver tissues and increased the apoptotic index of hepatocytes adjacent to hepatic lesions, foci and neoplastic nodules. The development of neoplastic nodules was also decreased, resulting in complete inhibition of hepatocellular carcinoma. These findings show bcl-xs to decrease precancerous hepatic lesions and inhibit the occurrence of hepatocellular carcinoma in rats by means of its pro-apoptotic activity. Since in humans, liver cirrhosis is known to predispose toward hepatocellular carcinoma and to frequently be associated with recurrence of liver tumors, 17, 18 bcl-xs gene therapy may be effective in both preventing and inhibiting the occurrence and recurrence of liver tumors.
From a practical standpoint, low-field-strength longGene Therapy Figure 6 . duration electric pulses increase in vivo plasmid DNA transfer to tumor cells (10 pulses; 800 V/cm; 4 ms per pulses), 26 normal liver cells (8 pulses; 250 v/cm; 50 ms per pulses) 27 and normal skeletal muscle (6 pulses; 200 v/cm; 50 ms per pulses). 30 In the present experiment, transfer of the bcl-xs plasmid encapsulated in liposomes by in vivo electroporation with a pincette electrode under conditions of 8 pulses, 70-100 v/cm, and 50 ms per pulse significantly inhibited the development of rat liver tumors at both sites of electrode contact and sites 0.5-1.0 cm away from the electrode. Moreover, CAT mRNA of the reporter gene was expressed at sites of contact with the electrode, as well as 0.5-1.0 cm away from the electrode, although less than at contact sites, meaning that expression of the reporter gene extends beyond the border of the electrode (a circle 1 cm diameter). It was reported that when plasmid pCMV-luciferase was transferred into skeletal muscle by electric square-wave pulses of low field strength (less than 300 V/cm) and long duration (more than 1 ms), the electric pulses increased gene transfer not only via cell permeabilisation but also by a direct effect on the DNA molecule, promoting DNA migration and cellular uptake, 30 and the electrotransfer resulted in long-lasting expression. For example, stable expression of fibroblast growth factor 1 plasmid in skeletal muscle was observed for at least 9 months. 30 It has also been speculated that target cells are genetically modified by the electrotransfer of plasmids, which are subsequently expressed for an extended period. 31 It appeared that bcl-xs plasmids were transferred into hepatocytes from the site of electrode contact via cell permeabilisation, and that they then migrated away from the electrode contact site as the result of a direct modifying effect of the pulses on the plasmid and that bcl-xs protein was expressed for several weeks at least, an adequate time for bcl-xs to inhibit the development of hepatocellular carcinoma.
Figure 8 (a) Apoptotic index of hepatic lesions and hepatocytes adjacent to hepatic lesions. For an explanation of the procedure, see
Cationic empty liposomes (EL-C-01) enhanced the expression of CAT plasmids via in vivo electroporation in normal rat livers. Our previous experiment also indicated that encapsulating bcl-2 antisense with that EL-C-01, forming particles with a constant diameter (approximately 100 nm), enhances the electric transfer of DNA. It appears that DNA particles encapsulated in liposomes may pass through pores produced by electroporation, and that DNA uptake can be increased by the combination of in vivo electroporation and empty liposomes. 7 Although transfer of bcl-xs plasmids via in vivo electroporation can transfer the bcl-xs gene selectively to the desired site, ie, hepatocellular carcinoma or a precancerous lesion, if the bcl-xs plasmid is taken up by normal hepatocytes, the plasmid becomes toxic. However, it was reported that c-myc-or c-erb-2-transformed murine mammary cells are extremely sensitive to apoptosis induced by the bcl-xs adenovirus vector, whereas immortalized nontransformed murine mammary cells are relatively resistant to apoptosis induced by this vector. 13 Given that hepatic precancerous cells and hepatocellular carcinoma overexpress c-myc and that the expression of c-myc in normal hepatocytes is minimal, many tumor cells and precancerous cells were killed while normal hepatocytes appeared to be protected from apoptosis by bcl-xs.
Electroporetic transfer of the bcl-xs plasmid immediately after the surgical resection of liver tumors apprears to prevent liver cirrhosis and decreases the recurrence of liver tumors. In a previous study, 7 the electroporetic transfer of bcl-2 antisense oligonucleotides decreased bcl-2 mRNA expression and inhibited the development of hepatocellular carcinoma at sites of electrode contact, but not at sites away from the electrode. However, with the administration of the bcl-xs plasmid, rat hepatocarcinogenesis was inhibited at both the sites of electrode contact and sites away from the electrode. The use of in vivo electroporetic transfer of plasmid DNA may be effective for treating disease which has spread over a wide area, such as liver cirrhosis.
The results of this experiment show bcl-xs to inhibit the occurrence and growth of rat hepatocellular carcinoma, and that transfer of the bcl-xs gene may be effective in preventing liver tumors as well as inhibiting their recurrence.
Materials and methods
Production of bcl-xs plasmid
Total RNA was isolated from the livers of 6-week-old Sprague-Dawley rats and reverse transcribed into firststrand cDNA by using random primers (Promega, Madison, WI, USA) and RNase H-reverse transcriptase (Superscript II; Gibco, BRL, Rockville, MD, USA). The following oligonucleotide primers based on human bcl-xs cDNA sequence 10 were synthesized (OligoExpress, Amersham Pharmacia Biotech, Tokyo, Japan).
Forward: TTGGACAATGGACTGGTTGA, Reverse: GTAGAGTGGATGGTCAGTG.
The first-strand cDNA was subjected to 40 cycles of PCR amplification (1-min denaturation at 94°C, 2-min annealing at 55°C, and 2-min extention 72°C), with a final extension phase of 7 min at 72°C, and the amplified products were resolved through 1.5% agarose gels. The 576 bp-band of bcl-xs cDNA was obtained, and no nonspecific production was detected. A 15 ng sample of bcl-xs cDNA was inserted into the multiple cloning site downstream of the CMV promoter of the expression vector, pCR3.1 (Invitrogen, San Diego, CA, USA) by TA-cloning. pCR3.1-bcl-xs was also digested by BamHI, and the bcl-xs cDNA obtained was inserted into the BamHI site of pUC 18 (Invitrogen) and transformed into TOP10FЈ-competent cells. pUC 18-bcl-xs was extracted, purified with a Wizard Plus Midipreps DNA Purification System (Promega, Madison, WI, USA), and the cDNA sequence was analyzed by ABI PRISMS 377 (Applied Biosystems Foster City, CA, USA). The resulting sequence was the same as that of the bcl-x short cDNA of Sprague-Dawley rats submitted in the gene bank (accession AF 136230).
pCR3.1-bcl-xs was amplified in E. coli strain TOP10FЈ and then isolated and purified with the Wizard Plus Midipreps DNA Purification System (Promega). Saline (2.3 ml) containing 500 g of purified pCR3.1-bcl-xs was combined with 0.2 ml of cationic empty liposome solution (Coatsome-EL-C-01; Nihon Yushi, Tokyo, Japan), gently mixed, and incubated for 30 min at room temperature and fresh saline was added at a final volume of 12.5 ml. Coatsome-EL-C-01 are cationic empty liposomes, which can form particles encapsulating DNA with a constant diameter, and consists of l-␣-dipalmitoylphosphatidyl cholin (52 mol), cholesterol (40 mol), and stearylamine (8 mol) in 3 ml saline solution. Under these conditions, the liposomes encapsulate DNA in cationic particles of approximately 100 nm diameter with 80% encapsulative efficiency. 7 In vivo gene transfer Sixty 4-week-old male Sprague-Dawley rats were purchased from Japan SLC (Shizuoka, Japan). After housing them in metal cages in animal quarters with controlled temperature (21-22°C), humidity (30-50%) and light (12-h cycle) for 2 weeks, the animals were randomly divided into three groups of 20 rats each and given drinking water containing NNM 175 mg/l for 8 weeks. From week 9 until the end of the experiment, the rats were given only ordinary tap water to drink. At weeks 1, 4 and 7, all rats were subcutaneously injected with 0.25 mg/ml atropine sulfate (Sigma, St Louis, MO, USA). Ten minutes later, the rats were injected with 15 mg/kg sodium pentobarbital i.p. (Abbott Laboratory, North Chicago, IL, USA). After the animals were completely anesthetized, the liver was exposed by making a transverse incision in the abdomen. The left lobe of the liver was exposed by drawing it through the incision, and pCR3.1-bcl-xs plasmid encapsulated in liposomes (group 1), pCR3.1 encapsulated in liposomes (group 2), or liposomes only (group 3), respectively, were injected into it at a dose of 80 g plasmid/kg body weight in saline (0.5 ml). One minute later, the site where the plasmid was injected, was sandwiched in a pincette electrode with circular poles 1 cm in diameter (positive and negative). Eight electrical pulses with a current of 0.5 A, electric-field strength of 70-100 V/cm, and a pulse duration of 50 ms were delivered to the left lobe with a BTX 500 optimizer and a BTX T820 standard square wave electroporator (BTX, San Diego, CA, USA). This procedure did not increase the temperature of the liver by more than 1°C.
At week 11, all rats were killed by deep ether anesthesia. Sections (2 or 3 mm thick) were taken from the two lesions occurring where the electrode poles had made contact, and 0.5-1.0 cm away from the site of electrode contact in the left lobe (Figure 1a) . The sections were fixed with cold Zamboni's solution, embedded in paraffin, and two serial 3-m-thick sections were cut. For histological analysis, each section from the different groups was stained with hematoxylin and eosin, and the number and mean area of foci, neoplastic nodules and hepatocellular carcinomas in the liver were measured with 'Image Hyper' software (InterQuest, Osaka, Japan).
RT-PCR
Total RNA was extracted with an RNA isolation kit (Purescript; Gentra System, Minneapolis, MN, USA), treated with DNase, extracted with phenol/chloroform (1:1) and precipitated with 1/10 volume of 3 m sodium acetate and two volumes ethanol. The total RNA was suspended in 35 l of DEPC-treated water containing 10 units RNasin and measured spectrophotometrically. The total RNA (1 g) from different groups was used for cDNA synthesis with avian myeloblastosis virus (AMV) reverse transcriptase XL (RNA PCR kit, ver. 2, Takara, Shiga, Japan). First-strand synthesis was performed at 55°C for 60 min. PCR was performed in PCR buffer (10 mm Tris-HCl, pH 8.3, 50 mm KCl, 1.5 mm MgCl 2 and 0.1% (W/V) gelatin) containing 200 m of each dNTP and 1.25 units of Taq polymerase and the upstream primer (5ЈACCGTTCAGCTGGATATTACG3Ј) and the downstream primer (5Ј CATGATGAACCTGAATCGCC 3Ј). Forty cycles of denaturation (94°C, 1 min), annealing (55°C, 2 min), and extention (72°C, 1 min) were conducted, with a final 7-min extension. PCR products (475 bp) were electrophoresed on a 1.5% agarose gel containing ethidium bromide. The levels of CAT cDNA were determined with FLA 2000 Science Imaging System (Fuji Film, Tokyo, Japan) and normalized relatively by ␤-actin levels.
Western blotting analysis
At week 11, the tissues from both sites that was sandwiched between the electrode and sites 0.5-1.0 cm away from electrode in the left lobe were lysed in a lysis buffer 20 mm Tris HCl buffer (pH 7.4), 1% Triton, 0.1% sodium deoxycholate, 10 g/ml aprotinin, 10 g/ml leupeptin and 1 mm phenylmethylsulfonyl fluoride. After removing the cell debris by centrifugation at 14 000 g for 30 min, the protein concentration was estimated with a Micro Protein Assay Reagent kit (Pierce, Rockford, IL, USA). A 50 g sample of each protein lysate was resolved in 14% SDS-polyacrylamide gel and transferred on to a PVDF menbrane (Millipore, Bedford, MA, USA) by semidry Gene Therapy Western blotting. After preblocking in 5% nonfat skim milk in Tris-buffered saline Tween (pH 7.6) (T-TBS) at room temperature for 1 h, the membrane was incubated with a rabbit anti-rat bcl-x polyclonal antibody (1:150) (Santa Cruz, Santa Cruz, CA, USA). After washing three times with T-TBS, the membrane was incubated with horseradish peroxidase-conjugated goat anti-rabbit IgG antiserum (1:1500) (Amersham Pharmacia Biotech, Little Chalfont, UK) for 1 h. After three washes, immunoblots were developed with the ECL chemiluminescence system (Amersham Pharmacia Biotech) to visualize bcl-x protein bands. The bcl-xs and bcl-xL bands were distingushed by molecular weight markers. The levels of bcl-xs and bclxL proteins were determined with Eagle Sight Image Capture and Analysis Soft Ware (Stratagene, La Jolla, CA, USA) and normalized by ␤-actin levels.
Apoptotic index
Sections were taken from both sites of electrode contact and sites away from electrode, and fixed with 4% paraformaldehyde, embedded in paraffin, and cut into serial 3-m-thick sections. Each serial paraffin section was dewaxed in xylene, rehydrated in ethanol, and incubated with 20 g/ml proteinase K in phosphate-buffered saline (PBS, pH 7.2) at room temperature for 15 min to quench endogenous peroxidase. The slides were then incubated with the mixture of terminal transferase and digoxigenin-11-UTP and ATP, and the anti-digoxigenin conjugated peroxidase solution (Apop. Tag in situ apoptosis detection kit: Oncor, Gaithersburg, MD, USA) 32 was then applied to the slide. Color was developed with diaminobenzidine.
Statistics
Results are expressed as mean ± s.e. Standard descriptive statistics, Student's t test and Fisher's exact probability test, were used. A P value of Ͻ0.05 was considered to indicate a significant difference between groups.
